Keywords: UCB, Cimzia, EU approval, Rheumatoid arthritis, anti-TNF

UCB’s Cimzia approved for RA in Europe

Article | 07 October 2009

Print This

Belgian drugmaker UCB says that the European Commission has approved Cimzia (certolizumab pegol), in combination with MTX, for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in